PBH – Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare In

PBH

$86.97

Name : Prestige Consumer Healthcare In

Sector : Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Mark. Cap: $4,297,596,416.00

EPSttm : 4.29

Prestige Consumer Healthcare In

$86.97

1.22%

$1.07

Float Short %

3.24

Margin Of Safety %

-4

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.12

EPS Last/This Y

0.46

EPS This/Next Y

0.25

Price

86.97

Target Price

90.8

Analyst Recom

2.29

Performance Q

1.17

Relative Volume

1.01

Beta

0.46

Ticker: PBH

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	PBH	82.03	0.09	1.00	62
2025-04-15	PBH	80.93	0.12	0.00	66
2025-04-16	PBH	79.78	0.12	0.00	66
2025-04-17	PBH	80.2	0.12	0.00	66
2025-04-18	PBH	80.28	0.12	0.00	66
2025-04-21	PBH	78.57	0.12	0.00	66
2025-04-22	PBH	80.17	0.12	0.00	66
2025-04-23	PBH	79.71	N/A	N/A	0
2025-04-24	PBH	79.43	N/A	N/A	0
2025-04-25	PBH	80.54	0.042553191489362	999.99	49
2025-04-28	PBH	80.95	0.042553191489362	999.99	49
2025-04-29	PBH	81.85	0.04	999.99	49
2025-04-30	PBH	81.11	0.04	999.99	49
2025-05-01	PBH	82.23	0.04	999.99	49
2025-05-02	PBH	84.15	0.04	0.00	49
2025-05-05	PBH	82.97	0.04	0.00	49
2025-05-06	PBH	80.99	0.04	0.00	49
2025-05-07	PBH	81.35	0.04	0.05	55
2025-05-08	PBH	87.06	0.05	0.00	213
2025-05-09	PBH	87.3	0.05	0.00	213
2025-05-12	PBH	88.11	0.05	0.00	214
2025-05-13	PBH	87	0.05	0.00	214
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	PBH	82.12	26.6	22.6	4.50
2025-04-15	PBH	80.94	26.6	18.7	4.50
2025-04-16	PBH	79.86	26.6	18.9	4.50
2025-04-17	PBH	80.28	26.6	24.4	4.50
2025-04-18	PBH	80.28	26.6	22.7	4.50
2025-04-21	PBH	78.57	26.6	16.6	4.50
2025-04-22	PBH	80.23	26.6	28.7	4.50
2025-04-23	PBH	79.77	26.6	21.1	4.50
2025-04-24	PBH	79.47	26.6	21.6	4.50
2025-04-25	PBH	80.54	26.6	26.3	4.50
2025-04-28	PBH	80.95	26.6	24.1	4.50
2025-04-29	PBH	81.93	26.6	26.2	4.50
2025-04-30	PBH	81.23	26.6	20.3	4.50
2025-05-01	PBH	82.23	26.6	26.2	4.50
2025-05-02	PBH	84.19	26.6	29.5	4.50
2025-05-05	PBH	82.98	26.6	18.6	4.50
2025-05-06	PBH	81.01	26.6	15.9	4.50
2025-05-07	PBH	81.41	26.6	24.1	4.50
2025-05-08	PBH	87.04	26.6	42.4	4.50
2025-05-09	PBH	87.30	13.6	23.7	4.77
2025-05-12	PBH	88.04	13.6	25.2	4.77
2025-05-13	PBH	86.97	12.0	14.9	4.78
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	PBH	-21.56	2.93	3.22
2025-04-15	PBH	-21.56	2.93	3.22
2025-04-16	PBH	-21.56	2.93	3.22
2025-04-17	PBH	-21.56	2.93	3.22
2025-04-18	PBH	-21.56	2.93	3.22
2025-04-21	PBH	-21.56	2.52	3.22
2025-04-22	PBH	-21.56	2.52	3.22
2025-04-23	PBH	-21.56	2.52	3.22
2025-04-24	PBH	-21.56	2.52	3.22
2025-04-25	PBH	-21.56	2.52	3.22
2025-04-28	PBH	-21.56	1.95	3.39
2025-04-29	PBH	-21.56	1.95	3.39
2025-04-30	PBH	-21.56	1.95	3.39
2025-05-01	PBH	-21.56	1.95	3.39
2025-05-02	PBH	-21.56	1.95	3.39
2025-05-05	PBH	-21.56	0.95	3.39
2025-05-06	PBH	-21.56	0.95	3.39
2025-05-07	PBH	-21.56	0.95	3.39
2025-05-08	PBH	-21.56	0.95	3.39
2025-05-09	PBH	-21.56	0.95	3.39
2025-05-12	PBH	-20.89	-0.76	3.24
2025-05-13	PBH	-20.13	-0.76	3.24
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.32

Avg. EPS Est. Current Quarter

1.01

Avg. EPS Est. Next Quarter

1.2

Insider Transactions

-20.13

Institutional Transactions

-0.76

Beta

0.46

Average Sales Estimate Current Quarter

259

Average Sales Estimate Next Quarter

291

Fair Value

83.12

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

3.4

Max Drawdown 5-Year %

-25.8

Target Price

90.8

P/E

20.29

Forward P/E

17.28

PEG

4.3

P/S

3.78

P/B

2.35

P/Free Cash Flow

17.66

EPS

4.29

Average EPS Est. Cur. Y

4.78

EPS Next Y. (Est.)

5.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.86

Relative Volume

1.01

Return on Equity vs Sector %

-12

Return on Equity vs Industry %

4.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

14.9

Prestige Consumer Healthcare In

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 600

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

stock quote shares PBH – Prestige Consumer Healthcare Inc. Stock Price stock today

news today PBH – Prestige Consumer Healthcare Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PBH – Prestige Consumer Healthcare Inc. yahoo finance google finance

stock history PBH – Prestige Consumer Healthcare Inc. invest stock market

stock prices PBH premarket after hours

ticker PBH fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

PBH – Prestige Consumer Healthcare Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: PBH

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y